Indoor Biotechnologies Cleaning Products US 2018 Indoor Biotechnologies – The world leader in allergen detection systems – Indoor Biotechnologies specializes in products, services and product efficacy testing support for indoor air quality, environmental sciences, allergy and asthma, configured for research or for consumer use. Its mission is to improve patient and consumer care through research, education and developing cutting edge technologies that serve our clients and customers worldwide. In its 20+ year history, the company has built a reputation as the world leader in assessment of environmental exposure to allergens - in the home, workplace, schools and commercial buildings. Indoor Biotechnologies scientific team has many years of experience providing product efficacy testing and contract research support for anti-allergen products and devices. The company serves clients worldwide in a wide range of industries: from cleaning and consumer products, to indoor air quality, industrial hygiene, allergy vaccine manufacturing, biopharmaceutical industry, as well as academic and government researchers. Indoor Biotechnologies was founded in 1995 by Dr. Martin D. Chapman, formerly Professor of Medicine and Microbiology at the University of Virginia and a member of the UVA Asthma and Allergic Diseases Center. Dr. Chapman is a Fellow of the American Academy of Allergy, Asthma and Immunology and has served as a consultant to the U.S. National Institutes of Health, the Environmental Protection Agency, academic institutions and Fortune 500 companies. Indoor Biotechnologies has laboratory locations in the USA, United Kingdom and in India; and serves clients all over the world.